KTH VENTURES

Vi är den första investeraren i bolag som kommersialiserar forskning och idéer från KTH

Portfölj
Vi har över 60 aktiva bolag som alla bygger på resultat och idéer från KTH:s forskning och utbildning.

TERASi raises €11m seed round

TERASi raises €11m seed led by NATO Innovation Fund and JOIN Capital to deliver unjammable and undetectable communications for Europe’s defence and resilience
Läs hela nyheten →
Nyheter
The founders of Evam: Alex Hedberg, Florian Curinga and Mikael Erneberg
KTH Ventures exits Evam following new investment round
KTH Ventures AB, has exited its investment in Evam, following the company’s latest financing round led by Industrifonden and Fåhraeus Startup & Growth.
Founding engineer Fabian Zeiher, Sonia Horchidan CEO and Paris Carbone
KTH Ventures welcomes new portfolio company OrbDB Labs - Enabling reliable AI
KTH Ventures has supported establishment of OrbDB Labs, a KTH spin-off developing technology that enables companies to use AI predictions in automated business processes while controlling the level of risk they are willing to accept.
Self-sampling using Samplimy's capillary whole blood collection microsampler
KTH Ventures invests in Samplimy to transform access to biological sampling
KTH Ventures has invested in Samplimy Medical AB, a KTH spin-off developing innovative microsampling technology that enables painless and self-performed collection of blood and dermal interstitial fluid.
KTH VENTURES

KTH Ventures är KTH:s venture capital-bolag

Läs mer →